A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
Akelos Inc., a biotechnology company currently developing and commercializing a novel, non-opioid anti- hyperalgesic drug to treat chronic and neuropathic pain.